Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Morphic Holding Inc (NQ: MORF )

29.62 +0.91 (+3.17%)
Streaming Delayed Price Updated: 12:41 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Morphic Holding Inc

< Previous 1 2 Next >
MORF Stock Earnings: Morphic Holding Beats EPS for Q1 2024
MORF stock results show that Morphic Holding beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Recap: Morphic Holding Q4 Earnings
Via Benzinga
Stock Market Rally Attempt Underway; Micron, Nike, Amazon, Meta In Focus: Weekly Review
But it's not a confirmed uptrend yet. Nike, Amazon and Meta were in focus. 
Via Investor's Business Daily
Where Morphic Holding Stands With Analysts
Via Benzinga
Gold Moves Lower; TransCode Therapeutics Shares Surge
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher by around 30 points on Monday. The Dow traded down 0.07% to 33,939.93 while the NASDAQ rose 0.24% to... 
Via Benzinga
Topics Stocks
Exposures US Equities
3 Biotech Buyout Targets to Watch
The trio all have late-stage therapies with blockbuster potential. 
Via The Motley Fool
4 Analysts Have This to Say About Morphic Holding
Via Benzinga
Looking Into Morphic Holding's Return On Capital Employed
Via Benzinga
Morphic Holding: Q3 Earnings Insights
Morphic Holding (NASDAQ:MORF) reported its Q3 earnings results on Wednesday, November 2, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Morphic Therapeutic's Stock Plunges On Monday - Here's Why?
Since Friday, Morphic Therapeutic (NASDAQ: MORF) shares have plunged from $47.92 to $26.25 after the company announced the publication of an abstract discussing new EMERALD-1 phase 2a primary results... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138. 
Via Benzinga
Where Morphic Holding Stands With Analysts
Morphic Holding (NASDAQ:MORF) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Short Volatility Alert: Morphic Holding, Inc.
On Thursday, shares of Morphic Holding, Inc. (NASDAQ: MORF) experienced volatile short activity. After the activity, the stock price went up +11.64% to $31.93. The overall sentiment for MORF has been... 
Via Benzinga
The Surprise That Prompted Morphic Therapeutic To Dump 52% Over Two Days
The company is working on a treatment for ulcerative colitis. But competitive questions linger. 
Via Investor's Business Daily
Nasdaq Turns Higher; SCYNEXIS Shares Plunge
U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite trading higher on Monday. The Dow traded down 0.01% to 33,962.53 while the NASDAQ rose 0.26% to 13,246.15. The S&P 500... 
Via Benzinga
Topics Stocks
Exposures US Equities
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
Via Benzinga
Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to boost the performance and efficiency of research institutions. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023
Via Benzinga
3 Stocks That Could Skyrocket by This Time Next Summer
The best stocks to skyrocket in June have all done well in 2023 and over the past year. They definitely ought to be on your watchlist. 
Via InvestorPlace
More Than $47M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Although US stocks closed lower on Thursday, there were a few notable insider trades. 
Via Benzinga
Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Xerox, Hubbell, Spotify And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Nasdaq Composite dropping around 100 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Morphic Therapeutic's Ulcerative Colitis Candidate Shows Clinically Meaningful Improvements Across Measures, Stock Soars
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82. 
Via Benzinga
7 Biotech Stocks to Buy for 100% Returns
If you can handle the risks associated with high volatility, these biotech stocks to buy might double the returns in your portfolio. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
Upgrades 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.